Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

Summary

To define the safety of vaccination with APSV as determined by the reactogenicity of the vaccine and the development of expected and un-expected adverse events associated with vaccination. To assess the proportion of individuals who respond to vaccination with a "take" (those who form a visible lesion at the injection site) 6 to 8 days after the vaccination.

Timeline

Start

2002-05

Primary completion

—

Completion

2002-08

Drugs

Indications